Addus HomeCare (NASDAQ:ADUS) Hits New 1-Year Low – Time to Sell?

Addus HomeCare Corporation (NASDAQ:ADUS) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $90.89 and last traded at $92.00, with a volume of 82130 shares. The stock had previously closed at $92.30.

Analyst Upgrades and Downgrades

ADUS has been the subject of a number of recent analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Wednesday, February 25th. Stephens decreased their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Finally, Barclays decreased their price target on Addus HomeCare from $112.00 to $102.00 and set an “underweight” rating for the company in a report on Wednesday, March 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $133.22.

Addus HomeCare Stock Performance

The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock has a fifty day moving average of $103.30 and a 200-day moving average of $110.11. The stock has a market cap of $1.71 billion, a PE ratio of 17.66, a price-to-earnings-growth ratio of 1.26 and a beta of 0.96.

Insider Activity

In related news, EVP Darby Anderson sold 733 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $78,416.34. Following the transaction, the executive vice president owned 46,642 shares of the company’s stock, valued at $4,989,761.16. This trade represents a 1.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Brian Poff sold 2,041 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the transaction, the executive vice president directly owned 64,512 shares in the company, valued at approximately $6,901,493.76. This represents a 3.07% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 16,610 shares of company stock valued at $1,768,970. Insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Capital Research Global Investors lifted its position in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after purchasing an additional 268,192 shares during the period. Tributary Capital Management LLC lifted its position in Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares during the period. Freestone Grove Partners LP lifted its position in Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after purchasing an additional 135,246 shares during the period. 8 Knots Management LLC acquired a new stake in Addus HomeCare in the third quarter valued at about $6,075,000. Finally, Empowered Funds LLC lifted its position in Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the period. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.